1. Department of Health and Human Services. Prescription Drug Product Labeling: medication guide Requirements; Final Rule. Fed Regist. 1998;63:66378–400.
2. Department of Health and Human Services. medication guides for Prescription Drug Products. Title 21 Code of Federal Regulations. Pt. 208. 2004:115-6.
3. U.S. Food and Drug Administration. Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments and Proposed REMS Modifications. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM184128.pdf . Accessed March 29, 2012
4. U.S. Food and Drug Administration, Center for Drug Evaluation Research (CDER). Guidance for Industry: medication guides - Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM244570.pdf . Accessed March 29, 2012.
5. Stubbings J, Joshi RA, Hoffman JM. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists. Am J Health Syst Pharm. 2010;67:1547–54.